摘要
AbstractBiobanking facilities are well established in high-income settings, where substantial funding has been invested in infrastructure. In contrast, such facilities are much less developed in resource-restricted settings. However, low-and middle-income countries (LMICs) still face a disproportionately high infectious diseases burden. Thus, the further development of infrastructure facilities, including biobanks is warranted as an important component of this unfolding clinical research environment. This perspective manuscript summarises the challenges and enablers for biobanking in LMICs, with a particular focus on infectious diseases, incorporating some of the lessons learned from the recent coronavirus disease 2019 (COVID-19) pandemic.
机构地区
National Liver Institute, Menoufia University, Shibin el Kom 32511, Egypt Mounir Armanious Research Center (MARC), Giza 12561, Egypt,University Cote D’Azur, Nice 06103, France,International Agency for Research on Cancer, World Health Organization, Lyon 69372, France
出版日期
2022年12月13日（中国期刊网平台首次上网日期，不代表论文的发表时间）
